Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending June 24, 2003. The report is a notification of changes in directors' interests in the company's Ordinary Shares and does not contain financial performance data for a specific fiscal period.
Financial Metrics
The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a disclosure of equity movements related to employee benefit plans and does not include financial statements.
Material Changes
The filing details two specific transactions regarding directors' interests:
- US Retirement Savings Plan: On June 20, 2003, the number of Ordinary Share ADRs held by the GlaxoSmithKline US Retirement Savings Plan increased from 18,667,673 to 18,707,477 at an average price of $42.21. Director Dr. J.P. Garnier is noted as potentially interested in these shares as a beneficiary of the discretionary fund.
- Employee Trust Transfer: On June 19, 2003, Abacus (GSK) Trustees Limited transferred 9,540 Ordinary Shares from the GlaxoSmithKline Employee Trust to participants in the SmithKline Beecham Employee Share Option Plan 1991. Directors Dr. J-P Garnier and Mr. J.D. Coombe are noted as potentially interested in the shares held in this discretionary trust.
Guidance, Outlook, and Risks
The filing text does not provide guidance, outlook, management commentary on operations, risks, contingencies, or unusual items. The document is limited to regulatory disclosure of share ownership changes.
Key Facts for Investor Verification
- Verify the total number of shares held by the US Retirement Savings Plan (18,707,473 ADRs) and the average acquisition price ($42.21).
- Confirm the transfer of 9,540 Ordinary Shares from the GSK Trust to the 1991 Employee Share Option Plan.
- Note that the reported interests for Directors Dr. J.P. Garnier and Mr. J.D. Coombe are indirect, arising from their status as potential beneficiaries of discretionary employee funds rather than direct personal holdings.